ArticleIEEE transactions on bio-medical engineering2015

Pharmacokinetic Tumor Heterogeneity as a Prognostic Biomarker for Classifying Breast Cancer Recurrence Risk.

Majid Mahrooghy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.